Why does Meta reject aesthetics clinic ads?

What are the most common reasons Meta rejects an aesthetics clinic ad?

Almost every rejection an aesthetics clinic sees traces back to one of a handful of policies: Health and Wellness, Personal Attributes, or the UK's own prescription-only medicine rule sitting on top of both. The table below covers the ones that come up most often, with the policy that triggers it and a compliant alternative that still lets you advertise the treatment.

Every one of these fixes points the same direction: sell the appointment, not the medicine and not the viewer's flaws. It is also the honest description of what a patient buys first: a consultation with a practitioner they trust.

Why does Meta restrict cosmetic and health ads in the first place?

Meta's Health and Wellness policy says ads promoting cosmetic products, procedures or surgeries "must be targeted to people aged at least 18 years or older". It does not ban the category. When the audience is 18 and over, Meta lists cosmetic procedures it allows, including dermal fillers, skin rejuvenation treatments, injectable treatments, chemical peels, micro-needling, non-ablative laser treatments and laser or light treatments, and it allows "general cosmetic products, procedures, operations depicting before-and-after transformation".

What the policy forbids for cosmetic products and procedures is narrower than most clinics assume. Ads cannot contain "statements of inferiority about physical appearance", which Meta defines as terms, descriptions or questions that are negative and attack someone's appearance, specific body parts or hygiene. Ads in a health context also cannot use clickbait tactics, including "promises of specific outcomes within a set time frame without disclaimers or qualifiers". Those two rules, plus the 18+ targeting requirement, account for most Health and Wellness rejections a clinic sees. (Meta's ban on close-ups that pinch fat applies to weight loss ads, not to cosmetic procedures generally.)

Meta allowing before-and-after images does not make every before-and-after ad safe in the UK. The CAP Code still requires ads not to mislead, so a comparison has to be genuine and representative of what a typical patient can expect, and a before-and-after for a prescription-only medicine treatment is still an ad for that medicine.

The Personal Attributes policy is a separate, older rule that catches a different kind of ad. It stops advertisers asserting or implying something about the specific person looking at the ad: their race, religion, age, sexual orientation, gender identity, disability, or physical or mental health, including a medical condition. Meta's own examples make the line clear: "New diabetes treatment available" is allowed and "Do you have diabetes?" is not. On age, Meta lists "Ready to upgrade your skin to look younger?" as not allowed, because it implies something about the person reading it, while "Our new lotion and creams fight wrinkles like never before!" is allowed because it describes the product.

What is the UK-specific layer on top of Meta's own rules?

Meta's policies are global. A UK aesthetics clinic has a second, stricter layer that applies regardless of what Meta's automated system lets through, because Meta approving an ad does not make it lawful in the UK.

1. Prescription-only medicines cannot be advertised to the public at all. CAP Code rule 12.12 states plainly that prescription-only medicines or prescription-only medical treatments may not be advertised to the public. Botulinum toxin is a prescription-only medicine, so naming it, its brands, or obvious stand-ins is advertising it. The ASA's enforcement notice goes further: indirect phrases that can only refer to the medicine, such as "wrinkle relaxing injections", are "just as much of a problem", and a reference to "anti-wrinkle injections" alongside a price will be seen as an ad for the medicine. The notice suggests promoting the service and the consultation instead; wording such as "a consultation for the treatment of lines and wrinkles" may be acceptable if nothing directly or indirectly advertises the medicine. Dermal fillers are not prescription-only and may be advertised, provided there is no implication that a prescription-only medicine is also available. Behind the CAP rule sits the Human Medicines Regulations 2012, which make advertising a prescription-only medicine to the public a legal matter, not only an advertising one.
2. No advertising directed at under-18s. Since 25 May 2022, CAP rules require that cosmetic intervention advertising must not be directed at under-18s through the choice of media or context, on top of Meta's own 18+ targeting requirement for the category.
3. No pressure selling or trivialising risk. In a 2025 ruling on a paid Instagram ad by EME Aesthetics & Beauty Academy for "liquid BBL" and hip filler, the ASA upheld both complaints: a Black Friday deadline ("Get your appointments before the price increase on the 30th November 2024!") put undue urgency on a decision that needs time and thought, and "HUUGE SAVINGS" and "MINIMAL PAIN" trivialised the risks. Meta ran the ad; the ASA still ruled against it.

Put together, a clinic that only checks its ad against Meta's policy is checking half the rulebook. For the wider picture of which channels to use, see the best way to market an aesthetics clinic in the UK. The CAP Code, the ASA's enforcement notice on botulinum toxin advertising, and the Human Medicines Regulations sit above Meta's approval, not below it.

How does Meta's ad review process actually work?

Every ad goes through review before it runs, covering its images, video, text, targeting and the page it links to. Meta does not publish much about how the system works ("we may not share some details about how our review systems work"), but it does say that re-reviews rely "more heavily on teams of human reviewers" than the initial review, and it keeps a help article titled "Why some ads are approved, then rejected". In practice that explains two things clinics find confusing: an ad can be approved, run, and be pulled later, and two near-identical ads can get different outcomes.

The first review reads what is literally in the ad and on the page. A compliant ad can be caught by a phrase read out of context, which is why Meta offers a re-review path rather than treating every rejection as final.

What should a clinic actually do when an ad is rejected?

Meta's own guidance sets out three options once you get the rejection email, which links to Meta Business Support Home and states the reason.

1. Edit the ad. Change the specific element Meta flagged, whether that is the image, the copy, the targeting or the landing page, then republish. It goes back into review automatically. This is the right first move for anything in the table above, since the fix is usually a single line of copy or one image swap.
2. Create a new ad instead. Useful if the ad format cannot be edited. Meta's guidance warns that deleting the rejected ad can cost you the ability to request a review of that specific decision, because the system may no longer have the information it needs.
3. Request another review. Available in Business Support Home if you believe the rejection was wrong. Meta states it aims to decide within 48 hours, and that this stage relies more on human reviewers than the initial automated pass. If the decision is reversed and the campaign is active, the ad starts delivering automatically. If it is rejected again, it stays rejected and you cannot request another review of the same ad.

Meta says plainly that requesting another review "will not hurt your standing with Meta in any way", so it is always worth doing when you are confident the ad follows the rules above and was likely caught by the automated system reading a phrase out of context.

How do repeated rejections put the ad account at risk?

A single rejected ad is routine. The risk comes from a pattern. Meta's guidance says that if advertisers run ads that "severely or repeatedly violate our policies", it can go beyond rejecting ads and restrict the business account, the ad account, the Page and/or the user account from advertising. Its page on advertising restrictions lists what those restrictions can look like.

Meta also says that editing or deleting a rejected ad "will not remove the violation from your account". Severe or repeated violations are what trigger restrictions, not one rejection. In practice this means a clinic that keeps testing the same non-compliant angle, naming the medicine, running the before-and-after comparison, adding a countdown discount, builds up a violation history even if most of those ads never go live. The safer pattern is to treat every rejection as a signal to change the underlying approach (advertise the consultation, drop the comparison, remove the deadline), not just to reword the same ad until it slips through.

Does the landing page get checked too, not just the ad?

Yes, and clinics often fix the ad while forgetting the page it links to. Meta's review covers the ad's image, video, text and targeting, but also its destination, meaning the landing page or website the click lands on. A perfectly compliant ad that links to a page naming a prescription-only medicine, showing a before-and-after gallery, or running a countdown discount, can still be rejected, because the policy applies to the whole path from click to page, not only the creative itself. Before publishing, read your landing page the same way you would read the ad: no named medicine, no before-and-after that is not genuine and typical, and none for a prescription-only medicine treatment, no pain- or risk-minimising claims, and no artificial deadline. If your consultation booking page and your main treatment pages share a template, check both, since a rejection on one can be traced back to wording used sitewide.

This also matters for the UK-specific rules, since the CAP Code and the Human Medicines Regulations apply to the landing page independently of whether Meta's system happens to catch it. The ASA's rules apply to a clinic's own website as well as to paid ads, because the same "no promotion of a prescription-only medicine to the public" rule covers a treatments page exactly as it covers an Instagram post.

How does PatientFlow handle this?

PatientFlow runs every campaign from the clinic's own Meta ad account, so the compliance history, and the risk of a restriction, sits with an account the clinic owns and controls, not an account the clinic does not control. For Dr Motox that approach produced 160 deposit-paid bookings in four months at £36 each. The ads themselves are built around the consultation, never a named medicine or a before-and-after claim, because that is both the compliant approach and the one that produces a qualified enquiry: a patient who books a consultation has already decided to explore treatment, rather than reacting to a promise about a result.

Once ads are running cleanly, the next question is whether they produce patients: see how to measure aesthetics clinic ads through to bookings.

A pre-flight checklist before you publish an aesthetics ad

1. Check the ad, the image text and the landing page for any brand name or generic name of a prescription-only medicine. Remove it.
2. If you show a before-and-after, make sure the ad is targeted 18+, the images are genuine and typical, and the treatment is not a prescription-only medicine. If in doubt, show the clinic and the practitioner instead.
3. Read the headline back as a question aimed at the viewer's body ("Do you have...", "Ready to fix your..."). If it reads that way, rewrite it to describe the service instead.
4. Remove any claim about pain, risk or savings, any promise of a result by a date, and any artificial countdown or discount deadline.
5. Confirm the ad set's minimum age is 18 and that placements are not skewed toward a younger audience.
6. If an ad is rejected and you believe it complies with every point above, edit the smallest possible element first; only request a re-review if you are confident the rejection was a false positive.

This is general guidance on advertising platform policy and UK advertising rules, not legal advice. For a specific ad, check the current wording of the CAP Code and Meta's Transparency Center, since both are updated periodically.